Treatment
Drug clinical trials
We’re tracking 1,297 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06829043Enrolling by invitation
PET scan for uncertain thyroid nodules
This study uses a special PET scan (18F-FDG PET/CT) to get a clearer picture of thyroid nodules with uncertain biopsy results. The goal is to help doctors decide whether surgery is needed.
Bologna, ItalyAges 18 years+ - NCT06805032Enrolling by invitation
Testing muscle monitors in surgery with arms tucked
This trial tests how well two muscle monitors work when your arms are tucked in during surgery. It aims to see which type of monitor gives accurate readings when no muscle relaxants are used.
Jacksonville, FloridaAges 18 years+ - NCT06793293Enrolling by invitation
Laser therapy for c-section incision pain
This trial tests if a high-level laser can reduce pain and help healing after a cesarean section. If you've had a C-section and have incision pain, this treatment may offer relief without medication.
CairoAges 20–40 - NCT06786780Enrolling by invitationPhase 2
Predicting chemoradiation response with cervical cancer organoids
This trial is studying whether lab-grown mini-tumors (called organoids) from your cervical cancer biopsy can predict how well chemoradiation will work. It aims to create a tool to help doctors choose the best treatment for each patient.
Chongqing, ChinaAges 18 years+ - NCT06782399Enrolling by invitationEarly Phase 1
Drug screening for skin squamous cell cancer lesions
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
Boston, MassachusettsAges 18 years+ - NCT06741917Enrolling by invitationPhase 4
Low risk kidney stone surgery study
This study tests a low-risk surgery for removing kidney stones. It checks if the procedure is safe and effective for people with small to medium stones and no active infection.
TaipeiAges 20–75 - NCT06660264Enrolling by invitation
Pharmacist medication review with or without genetic testing
This trial tests whether a pharmacist review of your medications, plus information from a pharmacogenomic (PGx) test (which looks at how your genes affect your response to drugs), can help improve your medication plan. If you qualify, you'll get a free PGx test and a personalized medication review.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06606990RecruitingPhase 1
Testing the drug CX-5461 for advanced solid tumors
This trial tests a new drug called CX-5461 (also known as pidnarulex) in people whose cancer has spread and hasn't been helped by standard treatments. It looks at how your body responds to the drug, which may target cancers with specific DNA repair problems.
Bethesda, MarylandAges 18 years+ - NCT06573671Enrolling by invitation
Histiocytosis in people who inject drugs
This trial looks at a condition called PVP-histiocytosis, which can happen in people who inject drugs made from tablets containing polyvinylpyrrolidone (PVP). The goal is to study these cases to better understand the condition.
Tampere, PirkanmaaAges 18–70 - NCT06521892Enrolling by invitation
Improving antibiotic sales in Hubei pharmacies
This study tests ways to improve how community pharmacies in Hubei Province handle antibiotic sales without a prescription. It aims to find better practices to prevent misuse.
Wuhan, HubeiAges Any age - NCT06505005Enrolling by invitation
Pain Relief Patch for Muscle Pain and Better Sleep
This study tests whether a pain relief patch worn on the skin can help with moderate back, shoulder, or other muscle pain and improve sleep. You will be given either the active patch or a placebo patch to wear.
Tyrone, GeorgiaAges 18–65 - NCT06484192Enrolling by invitationPhase 4
Pain control after lower back fusion surgery
This trial tests a new pain management plan for people having spinal fusion surgery on their lower back. It aims to find the best way to control pain while reducing side effects.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06405295Enrolling by invitation
Intensive adjuvant therapy for BRCA-related triple-negative breast cancer
This trial tests an intensive add-on treatment for people with triple-negative breast cancer and a BRCA mutation who are at high risk of recurrence after surgery and standard treatments. The goal is to see if extra therapy helps prevent the cancer from coming back.
Beijing, Beijing MunicipalityAges 18–75 - NCT06100510Enrolling by invitationPhase 4
Platelet function test in healthy adults
This trial is collecting blood from healthy adults to establish a new reference range for a standard platelet function test. You may be eligible if you do not have any bleeding disorders, are not taking blood thinners or anti-inflammatory medications, and meet other lab criteria.
East Syracuse, New YorkAges 18 years+ - NCT06095284Enrolling by invitation
Antiseizure drug use in nursing homes before and after COVID-19
This study looks at how antiseizure medications are prescribed to long-term nursing home residents and how those prescriptions changed during the COVID-19 pandemic. It helps understand if prescribing patterns affected residents' health.
Richmond, VirginiaAges 21 years+ - NCT05769023Enrolling by invitation
Pilot test targeting HIV prevention for people who inject drugs
This pilot program studies where HIV risk is highest and uses that information to decide how prevention efforts should be delivered. If you’ve used opioids recently and you inject drugs, you may be invited to participate to help reduce HIV risk.
Baltimore, MarylandAges 18 years+ - NCT05739071Enrolling by invitation
Herbal tea study for bladder cancer urinary tract symptoms
This study tests whether drinking JING SI herbal tea can help with urinary tract symptoms in people with bladder cancer receiving treatment directly into the bladder. You may be able to help researchers understand whether this tea improves day-to-day bladder-related symptoms.
Taipei, TaiwanAges 20–100 - NCT05691517RecruitingPhase 1
Test drug CBX-12 in advanced cancers and monitor your response
This Phase 1 study tests how your body handles the drug CBX-12 in people with advanced solid cancers that have already tried prior treatments. It may help researchers learn safe dosing and how tumors respond, and you may be asked to provide biopsy samples.
Bethesda, MarylandAges 18 years+ - NCT05307666Enrolling by invitationPhase 4
Older adults using many medications may get simpler care
This study looks at whether older adults do better when their medication plan is simplified. You may be able to join if you’re at least 80, live in the community, and take 6 or more regular oral medications.
Edmonton, AlbertaAges 80 years+ - NCT04988256Enrolling by invitationEarly Phase 1
Test cyclosporine versus steroids for DRESS skin reaction
This trial compares two medicines—cyclosporine and steroid treatment—for a rare, serious drug reaction called DRESS. It aims to see which treatment controls the illness more safely and effectively.
Los Angeles, CaliforniaAges 18 years+ - NCT04633603Enrolling by invitation
Study of attitudes toward fever and fever care changes
This study looks at how people think about fever and how fever care works in the healthcare system. You may be asked to record details of fever episodes at home or in outpatient care to help researchers understand real-world fever management.
PécsAges Up to 100 years - NCT04504955Enrolling by invitation
Atopic dermatitis patient registry for medication safety and results
This study is a real-world registry that collects information from adults with atopic dermatitis (eczema) to track how newly started treatments work and how safe they are over time. It may help researchers and doctors better understand medication effects in everyday care.
Waltham, MassachusettsAges 18 years+ - NCT04399876Enrolling by invitationPhase 1
Testing an implantable device to study drug response in prostate cancer
This early-phase study uses a tiny implant placed during prostate cancer surgery planning to help researchers measure how tumors respond to treatment while still in the body. The results may help improve future treatment choices for men with intermediate- or high-risk prostate cancer.
Boston, MassachusettsAges 22 years+ - NCT04381611Enrolling by invitation
Study of glaucoma surgeries and laser treatments over time
This study looks at people with glaucoma or high eye pressure to understand how surgeries and laser treatments affect long-term outcomes. It may help doctors predict which treatments work best for different patients.
Lausanne, Canton of VaudAges 1–100
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,297 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.